The head of the Slovenian national advisory group on Covid-19 vaccination, Bojana Beović, has said that after the approval of the European Medicines Agency (EMA) for the Pfizer / BioNTech vaccine for children aged 12 or over, the group will recommend vaccinating children. in this state, especially those suffering from chronic diseases.
The Vaccination Advisory Group will meet this week to issue a formal opinion, which will then form the basis of the National Institute of Public Health (NIHZ) recommendations aimed at promoting vaccination of particularly vulnerable groups of children with chronic diseases. , as they could worsen the flow due to COVID-19 in such patients, Beović said.
She went on to say that German researchers had identified a possible cause of the side effects that appeared especially after vaccination with the AstraZeneca and Janssen vaccines. This is also important because the discovery will make it possible to improve the vaccine, as we want as many COVID-19 vaccines to be available during the period when vaccines can be selected.
In Slovenia, 39 percent of the adult population has already received the first dose of a vaccine and about a quarter have been fully vaccinated.
Beović said she could see no reason not to use the Pfizer / BioNTech vaccine for children after it was approved by the EMA.
The vaccine had previously been approved for children under 16 years of age.
Beović believes it makes sense to immunize them as Covid-19 may also prove to be quite serious in children while following the disease, they may suffer from Multisystem Inflammatory Syndrome in Children (MIS-C).
Another reason, according to her, to vaccinate them is to provide collective immunity to contain the epidemic.
Children can now register for vaccination on the eZvem portal as part of the general population, she said.
Looking ahead to the summer months, Beović said that a normal life without coronavirus restrictions could be possible once herd immunity was achieved.
For the Wuhan strain of coronavirus, this means 66% of the population, while the more virulent strains require higher rates.
If immunity rates are lower, restrictions will have to remain in place, she said.
Beovic warned that the epidemic was still quite widespread in Slovenia, stressing that the country had far more infections per capita than Austria or Italy.
In this respect, she expects the restrictions to exist for quite some time.